Immuneering Corporation (IMRX)

AI Score

Unlock

1.45

-0.01 (-0.68%)

At close: Apr 25, 2025, 3:59 PM

1.46

0.92%

After-hours: Apr 25, 2025, 04:32 PM EDT

Immuneering Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-18.05M	-14.6M	-14.08M	-14.31M	-15.08M	-12.6M	-12.19M	-13.6M	-13.25M	-12.84M	-11.53M	-12.9M	-10.78M	-8.53M	-7.99M	-6.23M	-5.84M	-4.4M	-3.6M	-3.2M
Depreciation & Amortization	93.43K	96.27K	97.85K	187.68K	97.07K	85.61K	-20.23K	189.63K	189.28K	204.53K	-82.94K	200.63K	52.5K	37.57K	35.11K	33.89K	32.21K	15.88K	15.99K	15.23K
Stock-Based Compensation	1.72M	1.64M	1.66M	1.47M	1.64M	1.48M	1.33M	1.27M	1.05M	1.07M	1.05M	897.65K	632.58K	636.81K	351.01K	182.22K	216.61K	310.46K	287.55K	272.14K
Other Working Capital	1.64M	21.86K	331.31K	-2.8M	1.71M	-16.48K	94.34K	-1.67M	-400.24K	-158.68K	1.08M	-800.92K	1.05M	148.04M	1.1M	29.42M	-218.1K	555.25K	151.94K	29.42M
Other Non-Cash Items	30.99K	46.55K	69.92K	1.57M	-313.03K	-822K	99.55K	-186.3K	-214.19K	-96.46K	-220.73K	103.53K	13.33M	8.55K	360.21K	354.05K	273.84K	309.64K	-267.57K	869.45K
Deferred Income Tax	n/a	n/a	n/a	n/a	-620.19K	620.19K	n/a	n/a	n/a	n/a	n/a	n/a	-13.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.69M	-657.59K	724.49K	-2.68M	1.88M	-794.68K	27.06K	-2.09M	473.7K	1.05M	782.34K	-586.47K	1.05M	-1.18M	1.16M	-126.31K	134K	586.71K	-66.68K	598.97K
Operating Cash Flow	-14.51M	-13.47M	-11.53M	-15.49M	-11.78M	-12.03M	-10.75M	-14.42M	-11.75M	-10.62M	-9.45M	-12.28M	-9.24M	-9.03M	-6.44M	-6.14M	-5.45M	-3.49M	-3.37M	-2.31M
Capital Expenditures	-9.36K	-5.27K	-32.77K	-37.48K	-170.92K	-57.15K	-86.69K	-27.99K	-69.3K	-393.13K	-165K	-115.05K	-13.05K	-11.35K	-19.82K	-16.56K	-38.06K	-5.6K	-5.4K	-4.35K
Cash Acquisitions	n/a	n/a	n/a	n/a	-3.3M	23.91M	n/a	n/a	-41.83M	486.94K	n/a	n/a	70.35K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-15.75M	-28.91M	n/a	n/a	-12.38M	-19.74M	-10.01M	-7.98M	-22.87M	-52.76M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	5.5M	n/a	5M	21.43M	19.05M	5M	9.25M	19M	20.6M	19.25M	32.33M	20.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-5.41M	n/a	21.43M	3.3M	-23.91M	9.25M	19M	41.83M	-486.94K	22.32M	12.52M	70.35K	-52.76M	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	5.49M	-5.42M	4.97M	21.39M	3.13M	-23.97M	9.16M	18.97M	8.15M	-880.08K	22.15M	12.4M	-22.81M	-52.77M	-19.82K	-16.56K	-38.06K	-5.6K	-5.4K	-4.35K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-40.99K	127.19K	n/a	979.92K	7.83K	21.45K	28.17M	239.41K	-184.68K	-17.21K	27.78K	193.11K	7.52K	118.49M	979.75K	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	-40.99K	4.36M	n/a	979.92K	7.83K	21.45K	28.17M	239.41K	-184.68K	-17.21K	27.78K	193.11K	7.52K	118.49M	25.77M	n/a	36.98M	n/a	n/a	998.31K
Net Cash Flow	-9.06M	-14.52M	-6.56M	6.88M	-8.63M	-35.98M	26.59M	4.79M	-3.78M	-11.52M	12.73M	316.92K	-32.04M	56.68M	19.31M	-6.16M	31.49M	-3.49M	-3.37M	-1.32M
Free Cash Flow	-14.52M	-13.48M	-11.56M	-15.53M	-11.95M	-12.08M	-10.84M	-14.45M	-11.82M	-11.02M	-9.61M	-12.4M	-9.25M	-9.05M	-6.46M	-6.16M	-5.49M	-3.49M	-3.37M	-2.32M